Annual SGA
$3.85 M
+$790.00 K+25.80%
August 31, 2024
Summary
- As of February 8, 2025, LEXX annual SGA is $3.85 million, with the most recent change of +$790.00 thousand (+25.80%) on August 31, 2024.
- During the last 3 years, LEXX annual SGA has fallen by -$1.12 million (-22.52%).
- LEXX annual SGA is now -40.86% below its all-time high of $6.51 million, reached on August 31, 2018.
Performance
LEXX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$918.70 K
-$401.20 K-30.40%
November 30, 2024
Summary
- As of February 8, 2025, LEXX quarterly SGA is $918.70 thousand, with the most recent change of -$401.20 thousand (-30.40%) on November 30, 2024.
- Over the past year, LEXX quarterly SGA has stayed the same.
- LEXX quarterly SGA is now -73.49% below its all-time high of $3.47 million, reached on May 31, 2018.
Performance
LEXX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$202.79 M
-$7.32 M-3.74%
November 30, 2024
Summary
- As of February 8, 2025, LEXX TTM SGA is -$202.79 million, with the most recent change of -$7.32 million (-3.74%) on November 30, 2024.
- Over the past year, LEXX TTM SGA has dropped by -$206.85 million (-5095.26%).
- LEXX TTM SGA is now -193584.43% below its all-time high of -$104.70 thousand.
Performance
LEXX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LEXX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +25.8% | 0.0% | -5095.3% |
3 y3 years | -22.5% | -3.1% | -4756.8% |
5 y5 years | +5.7% | -3.1% | -4756.8% |
LEXX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -22.5% | +25.8% | -47.4% | +98.7% | -63.0% | at low |
5 y | 5-year | -22.5% | +25.8% | -59.3% | +98.7% | -108.7% | at low |
alltime | all time | -40.9% | >+9999.0% | -73.5% | +3353.8% | <-9999.0% | at low |
Lexaria Bioscience Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Nov 2024 | - | $918.70 K(-30.4%) | $4.06 M(+5.4%) |
Aug 2024 | $3.85 M(+25.8%) | $1.32 M(+5.3%) | $3.85 M(+21.3%) |
May 2024 | - | $1.25 M(+121.1%) | $3.18 M(+15.6%) |
Feb 2024 | - | $567.20 K(-20.2%) | $2.75 M(-2.7%) |
Nov 2023 | - | $711.10 K(+10.4%) | $2.83 M(-7.7%) |
Aug 2023 | $3.06 M(-38.3%) | $644.40 K(-21.9%) | $3.06 M(+6.3%) |
May 2023 | - | $825.20 K(+28.0%) | $2.88 M(-24.3%) |
Feb 2023 | - | $644.50 K(-32.0%) | $3.80 M(-12.7%) |
Nov 2022 | - | $947.90 K(+105.0%) | $4.35 M(-12.2%) |
Aug 2022 | $4.96 M(-0.2%) | $462.30 K(-73.5%) | $4.96 M(-7.7%) |
May 2022 | - | $1.75 M(+45.9%) | $5.37 M(-8.7%) |
Feb 2022 | - | $1.20 M(-22.9%) | $5.88 M(+1.9%) |
Nov 2021 | - | $1.55 M(+77.8%) | $5.77 M(+16.1%) |
Aug 2021 | $4.97 M(+25.0%) | $873.60 K(-61.3%) | $4.97 M(-2.5%) |
May 2021 | - | $2.26 M(+107.1%) | $5.10 M(+21.8%) |
Feb 2021 | - | $1.09 M(+44.9%) | $4.18 M(+6.7%) |
Nov 2020 | - | $752.00 K(-24.9%) | $3.92 M(-1.3%) |
Aug 2020 | $3.98 M(+9.2%) | $1.00 M(-25.4%) | $3.97 M(+1.4%) |
May 2020 | - | $1.34 M(+62.2%) | $3.92 M(+9.7%) |
Feb 2020 | - | $827.30 K(+3.2%) | $3.57 M(-6.8%) |
Nov 2019 | - | $802.00 K(-15.2%) | $3.83 M(+5.2%) |
Aug 2019 | $3.64 M(-44.1%) | $945.50 K(-5.0%) | $3.64 M(-4.2%) |
May 2019 | - | $994.80 K(-8.7%) | $3.80 M(-39.4%) |
Feb 2019 | - | $1.09 M(+77.7%) | $6.27 M(-5.6%) |
Nov 2018 | - | $613.20 K(-44.5%) | $6.64 M(+2.0%) |
Aug 2018 | $6.51 M(+255.3%) | $1.11 M(-68.1%) | $6.51 M(+7.9%) |
May 2018 | - | $3.47 M(+137.5%) | $6.04 M(+106.4%) |
Feb 2018 | - | $1.46 M(+202.1%) | $2.93 M(+52.5%) |
Nov 2017 | - | $482.90 K(-23.5%) | $1.92 M(+4.7%) |
Aug 2017 | $1.83 M(+50.7%) | $631.20 K(+78.7%) | $1.83 M(+19.2%) |
May 2017 | - | $353.20 K(-21.9%) | $1.54 M(+7.3%) |
Feb 2017 | - | $452.10 K(+14.1%) | $1.43 M(+17.4%) |
Nov 2016 | - | $396.40 K(+18.0%) | $1.22 M(+0.4%) |
Aug 2016 | $1.22 M(-31.0%) | $336.00 K(+35.1%) | $1.22 M(-11.9%) |
May 2016 | - | $248.70 K(+3.9%) | $1.38 M(-15.3%) |
Feb 2016 | - | $239.40 K(-38.9%) | $1.63 M(-11.5%) |
Nov 2015 | - | $392.00 K(-21.6%) | $1.84 M(+4.4%) |
Aug 2015 | $1.76 M | $500.00 K(+0.4%) | $1.76 M(-4.3%) |
May 2015 | - | $497.90 K(+10.6%) | $1.84 M(+0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Feb 2015 | - | $450.10 K(+42.9%) | $1.83 M(+32.7%) |
Nov 2014 | - | $315.00 K(-45.6%) | $1.38 M(+10.1%) |
Aug 2014 | $1.27 M(+240.1%) | - | - |
Jul 2014 | - | $579.50 K(+20.5%) | $1.25 M(+63.7%) |
Apr 2014 | - | $480.80 K(+309.5%) | $763.00 K(+107.2%) |
Jan 2014 | - | $117.40 K(+64.9%) | $368.20 K(-1.1%) |
Oct 2013 | $372.30 K(-34.2%) | $71.20 K(-23.9%) | $372.30 K(-5.3%) |
Jul 2013 | - | $93.60 K(+8.8%) | $393.30 K(-10.9%) |
Apr 2013 | - | $86.00 K(-29.2%) | $441.30 K(-14.7%) |
Jan 2013 | - | $121.50 K(+31.8%) | $517.40 K(-8.5%) |
Oct 2012 | $565.40 K(-21.4%) | $92.20 K(-34.9%) | $565.40 K(+7.7%) |
Jul 2012 | - | $141.60 K(-12.6%) | $524.80 K(-30.3%) |
Apr 2012 | - | $162.10 K(-4.4%) | $753.00 K(+6.1%) |
Jan 2012 | - | $169.50 K(+228.5%) | $709.70 K(+6.8%) |
Oct 2011 | $719.00 K(+52.0%) | $51.60 K(-86.0%) | $664.30 K(-9.7%) |
Jul 2011 | - | $369.80 K(+211.3%) | $735.50 K(+76.5%) |
Apr 2011 | - | $118.80 K(-4.3%) | $416.80 K(+14.3%) |
Jan 2011 | - | $124.10 K(+1.1%) | $364.70 K(-22.9%) |
Oct 2010 | $473.00 K(+3.1%) | $122.80 K(+140.3%) | $473.10 K(+4.6%) |
Jul 2010 | - | $51.10 K(-23.4%) | $452.50 K(-21.8%) |
Apr 2010 | - | $66.70 K(-71.3%) | $578.70 K(-8.5%) |
Jan 2010 | - | $232.50 K(+127.5%) | $632.60 K(+37.9%) |
Oct 2009 | $459.00 K(-4.3%) | $102.20 K(-42.4%) | $458.90 K(+19.7%) |
Jul 2009 | - | $177.30 K(+47.0%) | $383.30 K(+16.5%) |
Apr 2009 | - | $120.60 K(+105.1%) | $329.00 K(-3.8%) |
Jan 2009 | - | $58.80 K(+121.1%) | $341.90 K(-17.6%) |
Oct 2008 | $479.40 K(-53.5%) | $26.60 K(-78.4%) | $414.80 K(-25.1%) |
Jul 2008 | - | $123.00 K(-7.9%) | $553.70 K(-40.7%) |
Apr 2008 | - | $133.50 K(+1.4%) | $933.10 K(-17.0%) |
Jan 2008 | - | $131.70 K(-20.4%) | $1.12 M(+8.7%) |
Oct 2007 | $1.03 M(+627.9%) | $165.50 K(-67.1%) | $1.03 M(+14.1%) |
Jul 2007 | - | $502.40 K(+54.5%) | $907.40 K(+98.4%) |
Apr 2007 | - | $325.10 K(+675.9%) | $457.30 K(+182.5%) |
Jan 2007 | - | $41.90 K(+10.3%) | $161.90 K(+8.7%) |
Oct 2006 | $141.50 K(+303.1%) | $38.00 K(-27.3%) | $148.90 K(+34.3%) |
Jul 2006 | - | $52.30 K(+76.1%) | $110.90 K(+89.2%) |
Apr 2006 | - | $29.70 K(+2.8%) | $58.60 K(+102.8%) |
Jan 2006 | - | $28.90 K | $28.90 K |
Oct 2005 | $35.10 K | - | - |
FAQ
- What is Lexaria Bioscience annual SGA?
- What is the all time high annual SGA for Lexaria Bioscience?
- What is Lexaria Bioscience annual SGA year-on-year change?
- What is Lexaria Bioscience quarterly SGA?
- What is the all time high quarterly SGA for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly SGA year-on-year change?
- What is Lexaria Bioscience TTM SGA?
- What is the all time high TTM SGA for Lexaria Bioscience?
- What is Lexaria Bioscience TTM SGA year-on-year change?
What is Lexaria Bioscience annual SGA?
The current annual SGA of LEXX is $3.85 M
What is the all time high annual SGA for Lexaria Bioscience?
Lexaria Bioscience all-time high annual SGA is $6.51 M
What is Lexaria Bioscience annual SGA year-on-year change?
Over the past year, LEXX annual SGA has changed by +$790.00 K (+25.80%)
What is Lexaria Bioscience quarterly SGA?
The current quarterly SGA of LEXX is $918.70 K
What is the all time high quarterly SGA for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly SGA is $3.47 M
What is Lexaria Bioscience quarterly SGA year-on-year change?
Over the past year, LEXX quarterly SGA has changed by $0.00 (0.00%)
What is Lexaria Bioscience TTM SGA?
The current TTM SGA of LEXX is -$202.79 M
What is the all time high TTM SGA for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM SGA is -$104.70 K
What is Lexaria Bioscience TTM SGA year-on-year change?
Over the past year, LEXX TTM SGA has changed by -$206.85 M (-5095.26%)